Claritev Corporation Reports Q2 2025 Financial Results

Multiplan Corp ( (CTEV) ) has released its Q2 earnings. Here is a breakdown of the information Multiplan Corp presented to its investors.

Claritev Corporation, formerly known as MultiPlan, is a healthcare technology, data, and insights company that focuses on enhancing affordability, transparency, and quality within the U.S. healthcare system by leveraging advanced technology and data analytics.

In its second-quarter earnings report for 2025, Claritev Corporation announced revenues of $241.6 million, marking a 3.5% increase from the previous year. Despite a net loss of $62.6 million, the company reported a significant improvement from the previous year’s loss, alongside a robust Adjusted EBITDA of $154 million.

Key financial highlights for the quarter include a substantial increase in net cash provided by operating activities, which rose to $61.2 million from $18.5 million in the previous year. The company also achieved a Free Cash Flow of $36.6 million, compared to a negative $7 million in the same quarter last year. Additionally, Claritev processed $43.8 billion in claim charges, identifying potential medical cost savings of approximately $6.3 billion.

Looking ahead, Claritev has updated its full-year 2025 guidance, projecting revenue growth of up to 2% compared to 2024, and a potential Free Cash Flow range from a $20 million usage to a $20 million generation. The company remains focused on its strategic transformation, aiming to drive growth and deliver value through its expanded market segments and international expansion.

Claritev’s management is optimistic about the company’s future, emphasizing its commitment to making healthcare more affordable and transparent. With a revitalized leadership team and a clear strategic direction, Claritev is poised for continued growth and transformation in the healthcare sector.